hlx07
mAbexperimental
Clinical trial activity
13 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
11
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02648490)
Timeline
Indications
Studied for
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Squamous Cell · Phase 2
- Colorectal Neoplasms · Phase 2
- Esophageal Neoplasms · Phase 2
- Nasopharyngeal Neoplasms · Phase 2
- Neoplasms · Phase 1/Phase 2
- Small Cell Lung Carcinoma · Phase 2
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Stomach Neoplasms · Phase 2
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- hlx07
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05360368 | Phase 1 | Mar 30, 2023 | Shanghai Henlius Biotech |
| NCT05354700 | Phase 2 | Mar 29, 2023 | Shanghai Henlius Biotech |
| NCT05215925 | Phase 2 | Feb 1, 2023 | Shanghai Henlius Biotech |
| NCT05513573 | Phase 2 | Dec 30, 2022 | Shanghai Henlius Biotech |
| NCT05221658 | Phase 2 | Aug 25, 2022 | Shanghai Henlius Biotech |
| NCT05290220 | Phase 2 | Aug 1, 2022 | Shanghai Henlius Biotech |
| NCT05239650 | Phase 2 | Jul 15, 2022 | Fudan University, Shanghai Henlius Biotech |
| NCT05238363 | Phase 2 | Jun 15, 2022 | Shanghai Henlius Biotech |
| NCT05246982 | Phase 2 | Mar 23, 2022 | Shanghai Henlius Biotech |
| NCT04976647 | Phase 2 | Nov 10, 2021 | Shanghai Henlius Biotech |
| NCT04297995 | Phase 2 | Apr 30, 2020 | Central South University, Chinese Academy of Medical Sciences, Harbin Medical University, Huazhong University of Science and Technology, Jiangsu Cancer Institute & Hospital, Peking University, Shanghai Henlius Biotech |
| NCT03577704 | Phase 1/Phase 2 (Phase 2) | Aug 8, 2018 | Shanghai Henlius Biotech |
| NCT02648490 | Phase 1 | Sep 1, 2016 | Henlix, Inc |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Henlius Biotech | For profit | 12 | 12 | 2 | 2018 |
| Central South University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Harbin Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Henlix, Inc | For profit | 1 | 1 | 1 | 2016 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Jiangsu Cancer Institute & Hospital | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2020 |
9 organizations
Page 1 / 1